Targeting of 3′-azido 3′-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues

Pharmaceutical Research

Volumn 18, Issue 4, 2001, Pages 467-473

  Dembri, A ^a   Montisci, M J ^a   Gantier, J C ^a   Chacun, H ^a   Ponchel, G ^a  

^a UNIV PARIS SUD   (France)

Author keywords

3 azido 3 deoxythymidine (AZT); Gastrointestinal reservoir of HIV; Intestinal epithelium; Lymphatic duct cannulation; Peyer's patches; Poly(isohexylcyanoacrylate) nanoparticles

Indexed keywords

2',3' DIDEOXYTHYMIDINE; CYANOACRYLATE DERIVATIVE; DRUG CARRIER; NANOPARTICLE; POLY(ISOHEXYLCYANOACRYLATE); UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; MICROSPHERE; POLYISOHEXYLCYANOACRYLATE; ZIDOVUDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TISSUE LEVEL; GASTROINTESTINAL MUCOSA; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; IMMUNOCOMPETENT CELL; INTESTINE EPITHELIUM; ISOTOPE LABELING; LYMPHOID TISSUE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; RAT; RESERVOIR; ANIMAL; DRUG EFFECT; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; WISTAR RAT;

ANIMALS; ANTI-HIV AGENTS; CYANOACRYLATES; DRUG DELIVERY SYSTEMS; INTESTINAL MUCOSA; LYMPHOID TISSUE; MICROSPHERES; RATS; RATS, WISTAR; ZIDOVUDINE;

EID: 0034743412     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011050209986     Document Type: Article

References (30)

1. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
2. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
3. Diagnostic strategies in HIV-infected patients with diarrhea
4. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms
5. Interactions of viruses and micropartlcles with apical plasma membranes of M cells: Implications for human immunodeficiency virus transmission
6. Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa
7. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood
8. Transport, metabolism and elimination mechanisms of anti-HIV agents
9. Mucoadhesion of colloidal particulate systems in gastrointestinal tract
10. Body distribution of azidothymidine bound to hexylcyanoacrylate nanoparticles after i.v. injection to rats
11. A simplified method of cannulating the intestinal lymphatics of the rat
12. Quantitative image analysis of HIV-1 infection in lymphoid tissue
13. Intestinal secretory IgA immune response against human immunodeficiency virus among infected patients with acute and chronic diarrhea
14. Mucoadhesion of latexes. II. Adsorption isotherms and desorption studies
15. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent
16. Uptake and translocation of microparticles in small intestine. Morphology and quantification of particle distribution
17. Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats
18. The quantitation of the absorption of microparticles into the intestinal lymph of Wistar rats
19. The intestinal uptake of particles and the implications for drug and antigen delivery
20. Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome
21. Azidothymidine homodinucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine
22. Body distribution of azidothymidine bound to nanoparticles after oral administration
23. Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles
24. Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles
25. Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: A possibility for antiviral drug targeting
26. Lymphoid organs function as major reservoirs for human immunodeficiency virus
27. 3′-substituted 2′,3′-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents
28. Synthesis and biological evaluation of prodrugs of zidovudine
29. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
30. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity